According to Ionis Pharmaceuticals 's latest financial reports the company's total liabilities are $2.60 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $2.60 B | 32.76% |
2022-12-31 | $1.96 B | 6.58% |
2021-12-31 | $1.83 B | 11.75% |
2020-12-31 | $1.64 B | 6.32% |
2019-12-31 | $1.54 B | 4.59% |
2018-12-31 | $1.48 B | 54.64% |
2017-12-31 | $0.95 B | 17.79% |
2016-12-31 | $0.81 B | 8.81% |
2015-12-31 | $0.74 B | 7.03% |
2014-12-31 | $0.69 B | 48.91% |
2013-12-31 | $0.46 B | 29.17% |
2012-12-31 | $0.36 B | 15.78% |
2011-12-31 | $0.31 B | 2.46% |
2010-12-31 | $0.30 B | -13.85% |
2009-12-31 | $0.35 B | -24.43% |
2008-12-31 | $0.46 B | 89.01% |
2007-12-31 | $0.24 B | 57.35% |
2006-12-31 | $0.15 B | -3.48% |
2005-12-31 | $0.16 B | -41.65% |
2004-12-31 | $0.28 B | 4.78% |
2003-12-31 | $0.26 B | -5.45% |
2002-12-31 | $0.28 B | 46.01% |
2001-12-31 | $0.19 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $3.14 M | -99.88% | Bahamas |
NRC Health
NRC | $73.48 M | -97.18% | ๐บ๐ธ USA |